JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus

TL;DR

**JPM Chase Financial filed a routine prospectus, keeping capital-raising options open.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026, related to its existing shelf registration statement (File No. 333-270004-01). This filing is a routine update for offering securities under a previously approved plan, indicating that the company is maintaining its flexibility to raise capital. For investors, this means JPMorgan Chase Financial Co. LLC is keeping its options open for future financing activities, which could impact the company's capital structure and potentially its stock value depending on the terms of any future offerings.

Why It Matters

This filing indicates JPMorgan Chase Financial Co. LLC is maintaining its ability to offer securities, providing flexibility for future capital raising that could affect the parent company's financial health and stock performance.

Risk Assessment

Risk Level: low — This 424B2 filing is a standard procedural update for a shelf registration, not an announcement of a specific offering, and thus carries minimal immediate risk.

Analyst Insight

Investors should note this as a routine administrative filing that maintains the company's financial flexibility. No immediate action is required, but it signals potential future capital market activities. Keep an eye out for subsequent filings that detail specific offerings.

Key Numbers

• 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed by JPMorgan Chase Financial Co. LLC.)
• 333-270004-01 — File No. (The registration statement number under which JPMorgan Chase Financial Co. LLC is offering securities.)
• 0001665650 — CIK (The Central Index Key for JPMorgan Chase Financial Co. LLC.)

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMorgan Chase & Co. (company) — Parent company of the filer
• 0001665650 (person) — CIK of JPMorgan Chase Financial Co. LLC
• 0000019617 (person) — CIK of JPMorgan Chase & Co.
• 333-270004-01 (dollar_amount) — File number for the shelf registration statement of JPMorgan Chase Financial Co. LLC
• 333-270004 (dollar_amount) — File number for the shelf registration statement of JPMorgan Chase & Co.
• 2026-03-24 (dollar_amount) — Filing date of the 424B2 prospectus

FAQ

Key Financial Figures

• $3,207,000 — l Company LLC Structured Investments $3,207,000 Uncapped Accelerated Barrier Notes Li
• $1,000 — ribed below. Minimum denominations of $1,000 and integral multiples thereof The no
• $7.50 — roceeds to Issuer Per note $1,000 $7.50 $992.50 Total $3,207,000 $24,05
• $992.50 — to Issuer Per note $1,000 $7.50 $992.50 Total $3,207,000 $24,052.50 $3,
• $24,052.50 — $7.50 $992.50 Total $3,207,000 $24,052.50 $3,182,947.50 (1) See "Supplemental
• $3,182,947.50 — .50 Total $3,207,000 $24,052.50 $3,182,947.50 (1) See "Supplemental Use of Proceeds
• $951.50 — en the terms of the notes were set, was $951.50 per $1,000 principal amount note. See "
• $56.154 — 60.00% of its Initial Value , which is $56.154 for the Fund and 3,300.768 for the Inde
• $93.59 — derlying on the Pricing Date, which was $93.59 for the iShares MSCI EAFE ETF and 5,501
• $2,664.00 — Maturity 180.00 80.00% 166.40% $2,664.00 170.00 70.00% 145.60% $2,456.00
• $2,456.00 — $2,664.00 170.00 70.00% 145.60% $2,456.00 160.00 60.00% 124.80% $2,248.00
• $2,248.00 — $2,456.00 160.00 60.00% 124.80% $2,248.00 150.00 50.00% 104.00% $2,040.00
• $2,040.00 — $2,248.00 150.00 50.00% 104.00% $2,040.00 140.00 40.00% 83.20% $1,832.00
• $1,832.00 — $2,040.00 140.00 40.00% 83.20% $1,832.00 130.00 30.00% 62.40% $1,624.00
• $1,624.00 — $1,832.00 130.00 30.00% 62.40% $1,624.00 120.00 20.00% 41.60% $1,416.00

Filing Documents

• jpm1969_424b2-10781.htm (424B2) — 215KB
• ex-filingfees.htm (EX-FILING FEES) — 8KB
• image1.gif (GRAPHIC) — 2KB
• image5.jpg (GRAPHIC) — 5KB
• image2.jpg (GRAPHIC) — 81KB
• image3.jpg (GRAPHIC) — 73KB
• image4.jpg (GRAPHIC) — 80KB
• 0001839882-26-016741.txt ( ) — 653KB
• ex-filingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT March 20, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments $3,207,000 Uncapped Accelerated Barrier Notes Linked to the Lesser Performing of the iShares MSCI EAFE ETF and the EURO STOXX 50 Index due March 25, 2031 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek an uncapped return of 2.08 times any appreciation of the lesser performing of the iShares MSCI EAFE ETF and the EURO STOXX 50 Index, which we refer to as the Underlyings, at maturity. Investors should be willing to forgo interest and dividend payments and be willing to lose some or all of their principal amount at maturity. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Payments on the notes are not linked to a basket composed of the Underlyings. Payments on the notes are linked to the performance of each of the Underlyings individually, as described below. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660MJS5 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement and "Selected Risk Considerations" beginning on page PS-3 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $7.50 $992.50 Total $3,207,000 $24,052.50 $3,182,947.50 (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $7.50 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $951.50 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 1-I dated April 13, 2023, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Underlyings: The EURO STOXX 50 Index (Bloomberg ticker: SX5E) (the "Index") and the iShares MSCI EAFE ETF (Bloomberg ticker: EFA) (the "Fund") (each of the Index and the Fund, an "Underlying" and collectively, the "Underlyings") Upside Leverage Factor: 2.08 Barrier Amount: With respect to each Underlying, 60.00% of its Initial Value , which is $56.154 for the Fund and 3,300.768 for the Index Pricing Date: March 20, 2026 Original Issue Date (Settlement Date): On or about March 25, 2026 Observation Date*: March 20, 2031 Maturity Date*: March 25, 2031 * Subject to postponement in the event of a market disruption event and as described under "General Terms of Notes — Postponement of a Determination Date — Notes Linked to Multiple Underlyings" and "General Terms of Notes — Postponement of a Payment Date" in the accompanying product supplement or early acceleration in the event of a change-in-law event as described under "General Terms of Notes — Consequences of a Change-in-Law Event" in the accompanying product supplement and "Selected Risk Considerations — We May Accelerate Your Notes If a Change-in-Law Event Occurs" in this pricing supplement Payment at Maturity: If the Final Value of each Underlying is greater than its Initial Value, your payment at maturit

View Full Filing

View this 424B2 filing on SEC EDGAR